Status of Ongoing Proceedings
For information on how to obtain public transcripts of proceedings, please contact the Registrar, Riaz Awadia, by phone at 613-288-9597 or by e-mail at Riaz.Awadia@pmprb-cepmb.gc.ca.
Dates of Upcoming Hearings or Pre-Hearing Conferences
| Case | Event | Date / Location |
|---|---|---|
| Procysbi - Horizon Therapeutics Canada | Hearing for Motion to Bifurcate, Strike Evidence, and for the Inspection and Production of Documents | January 15, 2020 Ian G. Scott Courtroom 100 Thomas-More Private Room BRS 230 |
Matters before the Board
| Excessive Pricing | |||||
|---|---|---|---|---|---|
| Patented Drug Product | Indication / Use | Patentee | Issue | Date of Notice of Hearing | Status |
| Procysbi | nephropathic cystinosis | Horizon Therapeutics Canada | Allegations of excessive pricing | February 27, 2019 Case Management |
|
| Differin Differin XP |
Acne | Galderma Canada Inc. | Failure to file (jurisdiction) |
|
|
Judicial Review of Board Decisions and Appeals
| Patented Drug Product | Indication / Use | Patentee | Issue | Date of Notice of Application | Status |
|---|---|---|---|---|---|
| Soliris | Paroxysmal Nocturnal Hemoglobinuria Atypical Hemolytic Uremic Syndrome |
Alexion Pharmaceuticals Inc. | Allegations of excessive pricing | January 20, 2015 | Court File A-237-19 (RE T-1596-17 Board Panel’s decision of Sept 20, 2017)
|
| Differin Differin XP | Acne | Galderma Canada Inc. | Failure to file (jurisdiction) | February 23, 2016 | Court File A-385-17
|
Report a problem or mistake on this page
- Date modified: